Department of Dermatology, University of Rzeszow, Rzeszow, Poland.
Department of Dermatology, University Hospital Fundacion Alcorcon, Madrid, Spain.
J Eur Acad Dermatol Venereol. 2020 Jun;34 Suppl 2:3-11. doi: 10.1111/jdv.16428.
Inflammation from skin conditions such as psoriasis, eczema-like atopic dermatitis (AD) and hand eczema (HE) and following dermatological procedures (post-acts) can result in intense itching and cutaneous pain. Dermo-cosmetics containing plant extracts have been shown to reduce or alleviate these symptoms.
Assessment of the tolerability and efficacy of a spray containing Rhealba\xAE Oat plantlets and Uncaria tomentosa extracts in adults and children with inflammatory skin diseases and after dermatological procedures.
Data from five open label studies were analysed (Study 1: adults with AD; Study 2: children with AD; Study 3: adults with psoriasis; Study 4: adults with HE; Study 5: adults who had undergone a dermatological procedure: laser, intense pulsed light, glycolic acid peeling, photodynamic therapy or cryotherapy procedure). In all studies, subjects could use the test product up to six times per day for symptom relief. Physical and functional signs of inflammation, treatment-emergent adverse events (TEAEs), soothing effect, changes in quality of life, cutaneous pain and cosmetic acceptability were compared pre- and postapplication.
A total of 176 subjects were enrolled across the five studies. Overall, investigators judged the dermatological tolerance of the test product containing Rhealba\xAE Oat plantlets extract and Uncaria tomentosa as good to excellent. All studies showed significant improvements in physical signs, reduction in itching and feeling of pain (P < 0.05). The soothing effect was evident after the first application. TEAEs were mostly mild, transient and occurred within the first few days of treatment. The majority of subjects reported improved QoL across the studies.
The dermo-cosmetic spray containing Rhealba\xAE Oat plantlets extract and U. tomentosa was well tolerated and efficacious in providing relief of symptoms associated with cutaneous pain from inflammatory skin diseases and following dermatological procedures; however, further studies are needed to rule out alternative explanations of symptom reduction such as natural history and response biases.
皮肤状况如银屑病、湿疹样特应性皮炎(AD)和手部湿疹(HE)以及皮肤科治疗后(后发性)引起的炎症会导致剧烈瘙痒和皮肤疼痛。含有植物提取物的皮肤护理产品已被证明可以减轻或缓解这些症状。
评估含有 Rhealba®燕麦植物苗和钩藤提取物的喷雾在患有炎症性皮肤病和皮肤科治疗后的成人和儿童中的耐受性和疗效。
对五项开放性标签研究的数据进行了分析(研究 1:成人 AD;研究 2:儿童 AD;研究 3:成人银屑病;研究 4:成人 HE;研究 5:接受过皮肤科治疗的成年人:激光、强脉冲光、甘醇酸脱皮、光动力疗法或冷冻疗法)。在所有研究中,受试者每天最多可使用测试产品六次以缓解症状。在使用前后比较了炎症的物理和功能体征、治疗中出现的不良事件(TEAEs)、舒缓效果、生活质量变化、皮肤疼痛和美容可接受性。
共有 176 名受试者参加了五项研究。总的来说,研究人员认为含有 Rhealba®燕麦植物苗提取物和钩藤的测试产品的皮肤耐受性良好至极佳。所有研究均显示物理体征显著改善,瘙痒和疼痛感减轻(P<0.05)。舒缓效果在第一次应用后即可显现。TEAEs 大多为轻度、短暂,发生在治疗的头几天内。大多数受试者报告在整个研究中生活质量得到改善。
含有 Rhealba®燕麦植物苗提取物和 U. tomentosa 的皮肤护理喷雾具有良好的耐受性,能有效缓解与炎症性皮肤病和皮肤科治疗后皮肤疼痛相关的症状;然而,还需要进一步的研究来排除症状减轻的其他解释,如自然史和反应偏倚。